New US Ozempic 3mL Pen Offering for Maintenance Dosing

According to Drugs@FDA, the Ozempic US label has been updated to reflect a new 3mL pen offering for a maintenance dose of 1mg. The new pen has a different NDC (0169-4130-13) and dials 4 doses of 1mg each. The new pen represents a total strength of 4 mg/3 mL and harmonizes the maximum pen strength offered in Europe. Below, FENIX provides thoughts on this new pen offering including potential reasons around manufacturing efficiencies.

About The Author

Matthew Maryniak

President of Fenix Group International

Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.

If you receive our email blasts, you already have an account.

Purchase Blast$599.00

You can read the article’s full content online after purchase.